In a more clinically-relevant setting, short-term cultures of primary patient-derived ovarian cancer (OC) cells were pretargeted with anti-CD44-FITC, upon which treatment with scFvFITC:sTRAIL induced apoptosis in 6 out of 7 treated samples (Fig. 2E). This evidence concerns the gene CD44 and ovarian cancer.